Domestic Terrorism: An Overview, & More from CRS
The problem of “domestic terrorism” is examined in a new report from the Congressional Research Service, along with an assessment of the government’s difficulty in addressing it.
“Since the terrorist attacks of September 11, 2001 (9/11), domestic terrorists–people who commit crimes within the homeland and draw inspiration from U.S.-based extremist ideologies and movements–have not received as much attention from federal law enforcement as their violent jihadist counterparts,” the report says.
Among other obstacles to an effective response, “The federal government lacks a process for publicly designating domestic terrorist organizations.” See Domestic Terrorism: An Overview by CRS Specialist Jerome P. Bjelopera, August 21, 2017.
Other new and updated reports from the Congressional Research Service include the following.
Confederate Names and Military Installations, CRS Insight, August 22, 2017
FY2018 National Defense Authorization Act: Selected Military Personnel Issues, August 22, 2017
Human Rights in China and U.S. Policy: Issues for the 115th Congress, July 17, 2017
North Korean Cyber Capabilities: In Brief, August 3, 2017
Justice Department’s Role in Cyber Incident Response, August 23, 2017
Office of Science and Technology Policy (OSTP): History and Overview, updated August 17, 2017
Remedies for Patent Infringement, July 18, 2017
Russia: Background and U.S. Interests, updated August 21, 2017
FAS commends the Senate Committee on Energy and Natural Resources for clearing a historic 75 pieces of legislation, including multiple crucial bills to confront the wildfire crisis.
The United States needs a strategic investment fund (SIF) to shepherd promising technologies in nationally vital sectors through the valley of death.
Standardizing support for Accessibility & Accommodations in federally funded research efforts would open opportunities for disabled scientists and their research programs.
The incoming administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases.